PubRank

Yacine Abed

Author PubWeight™ 51.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 2002 6.09
2 Human metapneumovirus infections in hospitalized children. Emerg Infect Dis 2003 3.99
3 Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis 2006 3.26
4 Respiratory tract reinfections by the new human Metapneumovirus in an immunocompromised child. Emerg Infect Dis 2002 3.13
5 Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J Infect Dis 2010 2.51
6 Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med 2009 2.24
7 Human parechovirus 3 and neonatal infections. Emerg Infect Dis 2005 2.02
8 Human metapneumovirus: a new player among respiratory viruses. Clin Infect Dis 2004 1.92
9 Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog 2010 1.81
10 Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors. J Infect Dis 2011 1.64
11 Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine 2008 1.48
12 Influenza virus resistance to neuraminidase inhibitors. Antiviral Res 2013 1.47
13 Sequence polymorphism of the predicted human metapneumovirus G glycoprotein. J Gen Virol 2004 1.44
14 Comparative evaluation of real-time PCR assays for detection of the human metapneumovirus. J Clin Microbiol 2003 1.44
15 Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir. Antiviral Res 2006 1.32
16 Influenza drug resistance. Semin Respir Crit Care Med 2011 1.25
17 Human metapneumovirus genetic variability, South Africa. Emerg Infect Dis 2005 1.15
18 Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants. Clin Infect Dis 2003 1.14
19 Quantification of human herpesvirus 8 by real-time PCR in blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's disease. J Med Virol 2002 1.10
20 Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus. Antimicrob Agents Chemother 2011 1.06
21 The H275Y neuraminidase mutation of the pandemic A/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets. J Virol 2012 1.01
22 The I222V neuraminidase mutation has a compensatory role in replication of an oseltamivir-resistant influenza virus A/H3N2 E119V mutant. J Clin Microbiol 2010 1.00
23 Whole-genome characterization and genotyping of global WU polyomavirus strains. J Virol 2010 0.96
24 Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model. PLoS One 2011 0.94
25 Human metapneumovirus, Peru. Emerg Infect Dis 2006 0.87
26 Multi-year study of human metapneumovirus infection at a large US Midwestern Medical Referral Center. J Clin Virol 2006 0.86
27 Activity of the oral neuraminidase inhibitor A-322278 against the oseltamivir-resistant H274Y (A/H1N1) influenza virus mutant in mice. Antimicrob Agents Chemother 2008 0.85
28 Parenteral peramivir treatment for Oseltamivir-resistant 2009 pandemic influenza A H1N1 viruses. J Infect Dis 2011 0.83
29 Comparative evaluation of three serological methods for detection of human herpesvirus 8-specific antibodies in Canadian allogeneic stem cell transplant recipients. J Clin Microbiol 2004 0.82
30 Human metapneumovirus infection in immunocompromised child. Emerg Infect Dis 2008 0.78
31 Evaluation of recombinant 2009 pandemic influenza A (H1N1) viruses harboring zanamivir resistance mutations in mice and ferrets. Antimicrob Agents Chemother 2013 0.77
32 Emergence of an oseltamivir-resistant influenza A/H3N2 virus in an elderly patient receiving a suboptimal dose of antiviral prophylaxis. J Clin Microbiol 2013 0.77